Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 4
1973 1
1976 1
1983 1
1985 4
1986 1
1987 1
1988 4
1989 4
1990 3
1991 3
1992 5
1993 5
1994 9
1995 9
1996 6
1997 6
1998 8
1999 10
2000 5
2001 13
2002 12
2003 14
2004 10
2005 22
2006 20
2007 38
2008 42
2009 46
2010 62
2011 79
2012 76
2013 58
2014 67
2015 70
2016 78
2017 82
2018 87
2019 92
2020 77
2021 108
2022 89
2023 95
2024 112
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,360 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. Among authors: chae ys. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ. Pai SG, et al. Among authors: chae yk. J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6. J Hematol Oncol. 2017. PMID: 28476164 Free PMC article. Review.
GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis.
Lee YJ, Shin KJ, Jang HJ, Ryu JS, Lee CY, Yoon JH, Seo JK, Park S, Lee S, Je AR, Huh YH, Kong SY, Kwon T, Suh PG, Chae YC. Lee YJ, et al. Among authors: chae yc. Dev Cell. 2023 Feb 27;58(4):320-334.e8. doi: 10.1016/j.devcel.2023.01.006. Epub 2023 Feb 16. Dev Cell. 2023. PMID: 36800996 Free article.
Diversity and complexity of cell death: a historical review.
Park W, Wei S, Kim BS, Kim B, Bae SJ, Chae YC, Ryu D, Ha KT. Park W, et al. Among authors: chae yc. Exp Mol Med. 2023 Aug;55(8):1573-1594. doi: 10.1038/s12276-023-01078-x. Epub 2023 Aug 23. Exp Mol Med. 2023. PMID: 37612413 Free PMC article. Review.
Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.
Kim ES, Velcheti V, Mekhail T, Yun C, Shagan SM, Hu S, Chae YK, Leal TA, Dowell JE, Tsai ML, Dakhil CSR, Stella P, Jin Y, Shames DS, Schleifman E, Fabrizio DA, Phan S, Socinski MA. Kim ES, et al. Among authors: chae yk. Nat Med. 2022 May;28(5):939-945. doi: 10.1038/s41591-022-01754-x. Epub 2022 Apr 14. Nat Med. 2022. PMID: 35422531 Free PMC article. Clinical Trial.
Thrap3 promotes nonalcoholic fatty liver disease by suppressing AMPK-mediated autophagy.
Jang HJ, Lee YH, Dao T, Jo Y, Khim KW, Eom HJ, Lee JE, Song YJ, Choi SS, Park K, Ji H, Chae YC, Myung K, Kim H, Ryu D, Park NH, Park SH, Choi JH. Jang HJ, et al. Among authors: chae yc. Exp Mol Med. 2023 Aug;55(8):1720-1733. doi: 10.1038/s12276-023-01047-4. Epub 2023 Aug 1. Exp Mol Med. 2023. PMID: 37524868 Free PMC article.
Pediatric Application of Cuffed Endotracheal Tube.
Kim JH, Ahn JH, Chae YJ. Kim JH, et al. Among authors: chae yj. West J Emerg Med. 2023 Apr 28;24(3):579-587. doi: 10.5811/westjem.59560. West J Emerg Med. 2023. PMID: 37278787 Free PMC article. Review.
PLCγ1: Potential arbitrator of cancer progression.
Jang HJ, Suh PG, Lee YJ, Shin KJ, Cocco L, Chae YC. Jang HJ, et al. Among authors: chae yc. Adv Biol Regul. 2018 Jan;67:179-189. doi: 10.1016/j.jbior.2017.11.003. Epub 2017 Nov 8. Adv Biol Regul. 2018. PMID: 29174396 Review.
1,360 results